Shares of Corbus Pharmaceuticals Holdings Inc. CRBP shed 3.52% to $1.37 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.45% to 12,519.95 and the Dow Jones Industrial Average DJIA falling 0.49% to 30,069.79. Corbus Pharmaceuticals Holdings Inc. closed $8.41 short of its 52-week high ($9.78), which the company achieved on August 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Fate Therapeutics Inc. FATE rose 37.80% to $83.77, Vanda Pharmaceuticals Inc. VNDA fell 0.75% to $13.25, and Viking Therapeutics Inc. VKTX fell 3.95% to $6.08. Trading volume (4.1 M) remained 593,620 below its 50-day average volume of 4.7 M.